179 related articles for article (PubMed ID: 12917444)
21. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein.
Orsi A; Fioriti L; Chiesa R; Sitia R
J Biol Chem; 2006 Oct; 281(41):30431-8. PubMed ID: 16908519
[TBL] [Abstract][Full Text] [Related]
22. Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP.
Rambold AS; Miesbauer M; Rapaport D; Bartke T; Baier M; Winklhofer KF; Tatzelt J
Mol Biol Cell; 2006 Aug; 17(8):3356-68. PubMed ID: 16707568
[TBL] [Abstract][Full Text] [Related]
23. Protection from cytosolic prion protein toxicity by modulation of protein translocation.
Rane NS; Yonkovich JL; Hegde RS
EMBO J; 2004 Nov; 23(23):4550-9. PubMed ID: 15526034
[TBL] [Abstract][Full Text] [Related]
24. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
Ma J; Lindquist S
Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
[TBL] [Abstract][Full Text] [Related]
25. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin.
Mangé A; Crozet C; Lehmann S; Béranger F
J Cell Sci; 2004 May; 117(Pt 11):2411-6. PubMed ID: 15126640
[TBL] [Abstract][Full Text] [Related]
26. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells.
Roucou X; Giannopoulos PN; Zhang Y; Jodoin J; Goodyer CG; LeBlanc A
Cell Death Differ; 2005 Jul; 12(7):783-95. PubMed ID: 15846375
[TBL] [Abstract][Full Text] [Related]
27. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
Bate C; Salmona M; Diomede L; Williams A
J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
[TBL] [Abstract][Full Text] [Related]
28. Cytosolic prion protein induces apoptosis in human neuronal cell SH-SY5Y via mitochondrial disruption pathway.
Wang X; Dong CF; Shi Q; Shi S; Wang GR; Lei YJ; Xu K; An R; Chen JM; Jiang HY; Tian C; Gao C; Zhao YJ; Han J; Dong XP
BMB Rep; 2009 Jul; 42(7):444-9. PubMed ID: 19643043
[TBL] [Abstract][Full Text] [Related]
29. Targeting of the prion protein to the cytosol: mechanisms and consequences.
Miesbauer M; Rambold AS; Winklhofer KF; Tatzelt J
Curr Issues Mol Biol; 2010; 12(2):109-18. PubMed ID: 19767654
[TBL] [Abstract][Full Text] [Related]
30. Cellular prion protein is implicated in the regulation of local Ca2+ movements in cerebellar granule neurons.
Lazzari C; Peggion C; Stella R; Massimino ML; Lim D; Bertoli A; Sorgato MC
J Neurochem; 2011 Mar; 116(5):881-90. PubMed ID: 21214552
[TBL] [Abstract][Full Text] [Related]
31. Involvement of mitochondria in endoplasmic reticulum stress-induced apoptotic cell death pathway triggered by the prion peptide PrP(106-126).
Ferreiro E; Costa R; Marques S; Cardoso SM; Oliveira CR; Pereira CM
J Neurochem; 2008 Feb; 104(3):766-76. PubMed ID: 17995926
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective functions of prion protein.
Roucou X; Gains M; LeBlanc AC
J Neurosci Res; 2004 Jan; 75(2):153-161. PubMed ID: 14705136
[TBL] [Abstract][Full Text] [Related]
33. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
Apodaca J; Kim I; Rao H
Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
[TBL] [Abstract][Full Text] [Related]
34. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation.
Kim BH; Lee HG; Choi JK; Kim JI; Choi EK; Carp RI; Kim YS
Brain Res Mol Brain Res; 2004 Apr; 124(1):40-50. PubMed ID: 15093684
[TBL] [Abstract][Full Text] [Related]
35. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome.
Jin T; Gu Y; Zanusso G; Sy M; Kumar A; Cohen M; Gambetti P; Singh N
J Biol Chem; 2000 Dec; 275(49):38699-704. PubMed ID: 10970892
[TBL] [Abstract][Full Text] [Related]
36. The truncated 23-230 form of the prion protein localizes to the nuclei of inducible cell lines independently of its nuclear localization signals and is not cytotoxic.
Crozet C; Vézilier J; Delfieu V; Nishimura T; Onodera T; Casanova D; Lehmann S; Béranger F
Mol Cell Neurosci; 2006 Aug; 32(4):315-23. PubMed ID: 16806967
[TBL] [Abstract][Full Text] [Related]
37. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.
Yedidia Y; Horonchik L; Tzaban S; Yanai A; Taraboulos A
EMBO J; 2001 Oct; 20(19):5383-91. PubMed ID: 11574470
[TBL] [Abstract][Full Text] [Related]
38. Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells.
Grenier C; Bissonnette C; Volkov L; Roucou X
J Neurochem; 2006 Jun; 97(5):1456-66. PubMed ID: 16696854
[TBL] [Abstract][Full Text] [Related]
39. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.
Massignan T; Biasini E; Lauranzano E; Veglianese P; Pignataro M; Fioriti L; Harris DA; Salmona M; Chiesa R; Bonetto V
Mol Cell Proteomics; 2010 Apr; 9(4):611-22. PubMed ID: 19996123
[TBL] [Abstract][Full Text] [Related]
40. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
Mishra RS; Bose S; Gu Y; Li R; Singh N
J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
